These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31630320)

  • 1. A Review of Antithrombotic Treatment in Critical Limb Ischemia After Endovascular Intervention.
    Gupta A; Lee MS; Gupta K; Kumar V; Reddy S
    Cardiol Ther; 2019 Dec; 8(2):193-209. PubMed ID: 31630320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Antithrombotic Regimens on Clinical Outcomes After Endovascular Intervention and Bypass Surgery for Infrapopliteal Artery Disease.
    Gupta A; Lee MS; Gupta K; Kumar V; Reddy S
    Cardiol Res; 2019 Oct; 10(5):255-267. PubMed ID: 31636793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of postoperative antithrombotic therapy on lower extremity outcomes after infrapopliteal bypass for chronic limb-threatening ischemia.
    Marcaccio CL; Patel PB; Wang S; Rastogi V; Moreira CC; Siracuse JJ; Schermerhorn ML; Stangenberg L
    J Vasc Surg; 2022 May; 75(5):1696-1706.e4. PubMed ID: 35074410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dual antiplatelet therapy after lower extremity revascularization for chronic limb-threatening ischemia.
    Ramanan B; Jeon-Slaughter H; Chen X; Kashyap VS; Kirkwood ML; Timaran CH; Modrall JG; Tsai S
    J Vasc Surg; 2021 Oct; 74(4):1327-1334. PubMed ID: 34023428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of rivaroxaban-based dual antithrombotic and antiplatelet therapies for symptomatic patients with lower-extremity peripheral artery disease post-revascularization: a retrospective cohort study.
    Ji Y; Wang B; Wu G; Zhang Y; Wang Q; Zhou M
    Ther Adv Chronic Dis; 2023; 14():20406223231213262. PubMed ID: 38085917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia.
    Thott O; Granath F; Malmstedt J; Wahlgren CM
    Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):403-410. PubMed ID: 28131536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of Evidence for Dual Antiplatelet Therapy after Endovascular Arterial Procedures: A Meta-analysis.
    Peeters Weem SM; van Haelst ST; den Ruijter HM; Moll FL; de Borst GJ
    Eur J Vasc Endovasc Surg; 2016 Aug; 52(2):253-62. PubMed ID: 27241270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal Strategy for Antiplatelet Therapy After Endovascular Revascularization for Lower Extremity Peripheral Artery Disease.
    Cho S; Lee YJ; Ko YG; Kang TS; Lim SH; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2359-2370. PubMed ID: 31734299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment.
    Robertson L; Ghouri MA; Kovacs F
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002071. PubMed ID: 22895926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the efficacy of aspirin monotherapy versus other antiplatelet therapy regimens in peripheral arterial disease.
    Beiswenger AC; Jo A; Harth K; Kumins NH; Shishehbor MH; Kashyap VS
    J Vasc Surg; 2018 Jun; 67(6):1922-1932.e6. PubMed ID: 29801560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation in addition to dual antiplatelet therapy has no impact on long-term follow-up after endovascular treatment of (sub)acute lower limb ischemia.
    Kronlage M; Blessing E; Müller OJ; Heilmeier B; Katus HA; Erbel C
    Vasa; 2019 Jul; 48(4):321-329. PubMed ID: 30958111
    [No Abstract]   [Full Text] [Related]  

  • 13. Peri-procedural complications following endovascular revascularization for critical limb ischemia.
    Compagnon A; Lazareth I; Fels A; Chatellier G; Emmerich J; Michon-Pasturel U; Priollet P; Yannoutsos A
    J Med Vasc; 2022 Oct; 47(4):175-185. PubMed ID: 36344028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
    Shammas AN; Jeon-Slaughter H; Tsai S; Khalili H; Ali M; Xu H; Rodriguez G; Cawich I; Armstrong EJ; Brilakis ES; Banerjee S
    J Endovasc Ther; 2017 Jun; 24(3):376-382. PubMed ID: 28440113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
    Desai K; Han B; Kuziez L; Yan Y; Zayed MA
    J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia.
    Singh GD; Armstrong EJ; Yeo KK; Singh S; Westin GG; Pevec WC; Dawson DL; Laird JR
    J Vasc Surg; 2014 May; 59(5):1300-7. PubMed ID: 24393279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design for the study Apixaban versus ClopidoGRel on a background of aspirin in patient undergoing InfraPoPliteal angioplasty for critical limb ischemia: AGRIPPA trial.
    Biagioni RB; Lopes RD; Agati LB; Sacilotto R; Wolosker N; Sobreira ML; de Freitas Soares BL; Joviliano EE; Bernardi WH; Junior VC; Caffaro RA; Fioranelli A; Van Bellen B; Casella IB; Fidelis RJR; Flumignan RLG; Comerota AJ; Ramacciotti E
    Am Heart J; 2020 Sep; 227():100-106. PubMed ID: 32730905
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.